Navigation Links
China Nepstar Chain Drugstore Acquires Drugstores in Beijing
Date:7/13/2009

SHENZHEN, China, July 13 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("China Nepstar" or the "Company"), the largest drugstore chain in China based on the number of directly operated stores, today announced that it has entered into a definitive agreement with Beijing Run Ze Tang Drugstore, to acquire its five drugstores in Beijing. This acquisition represents China Nepstar's first retail presence in Beijing, one of the most important markets in China in terms of store traffic and consumption power. The five stores being acquired have an average store size of 170 square meters, and are located in densely populated residential areas in Beijing. Closing of the acquisition is expected to be in August. The stores will be serviced by the Company's regional logistics center in Tianjin, where Nepstar has over 100 stores. Tianjin is approximately 120km to the southeast of Beijing.

Beijing is the capital city of China and one of the four municipalities under the jurisdiction of the central government. Beijing's per capita GDP amounted to RMB63,000 in 2008. At the end of 2008, Beijing had a total residential population of approximately 14 million, and a large number of visitors from China and worldwide. An average Beijing resident enjoyed a disposable income of RMB24,700 in 2008, higher than their counterparts in other affluent regions of mainland China.

Mr. Ian Wade, Co-Chief Executive Officer of China Nepstar, commented, "This acquisition represents the initial step for China Nepstar to enter into the Beijing market, which we believe to have significant development potential. This is also our first chance to showcase Beijing customers our wide product offerings and advanced store management. We plan to continue to expand in Beijing through gradual ramp-up in new store openings and high q
'/>"/>

SOURCE China Nepstar Chain Drugstore Ltd.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. China Medicine Receives Approval for a RMB 20 Million Loan
2. Perot Systems Selected to Implement Health Information Systems in China
3. Perot Systems Launches Website in Chinese to Support Expansion Into China
4. Winner Medical Signs PurCotton Sales Agreement With Consumer Products Leader in China
5. Tianyin Pharmaceutical Co., Inc. Launches Advertising Program on China Central Television (CCTV) for its Xuelian Chongcao Oral Liquid
6. Opening Day of Fi Asia-China 2009 Brings the Food Ingredients Industry to Shanghai
7. China Sky One Medical, Inc. Obtains Production License Renewal for Sumei Slim Patch
8. China Pharma Holdings, Inc. Announces SFDA Approval for Rosuvastatin Clinical Trials
9. Winner Medical to Benefit From the Increase of Tax Rebate Rate for Exports From China
10. China Medical Technologies Announces Selected Unaudited Preliminary Financial Results for the Fourth Fiscal Quarter and Full Year Ended March 31, 2009
11. Jiangbo Pharmaceuticals to Attend the 44th China New Drugs Trade Fair in Tianjin
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 2Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 3Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 5Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 6Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3HemCon Medical Technologies Inc signs exclusive global agreement with Zimmer Dental Inc to distribute oral surgery dressings 57154 1HemCon Medical Technologies Inc signs exclusive global agreement with Zimmer Dental Inc to distribute oral surgery dressings 57154 2Eat Healthy Helps Parents Make Every Bite Fast Frugal Fun and Eco Friendly 57151 1Eat Healthy Helps Parents Make Every Bite Fast Frugal Fun and Eco Friendly 57151 2Eat Healthy Helps Parents Make Every Bite Fast Frugal Fun and Eco Friendly 57151 3Eat Healthy Helps Parents Make Every Bite Fast Frugal Fun and Eco Friendly 57151 4Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 1Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 2Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 3Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 4